Effects of levonorgestrel-releasing intrauterine system and T380A intrauterine copper device on dysmenorrhea and days of bleeding in women with and without adenomyosis

Sefa Kelekci, Sefa Kelekçi, Kelekci S, Kelekci KH, Kiymet Handan Kelekci, Kıymet Handan Kelekçi, Yilmaz B, Bülent Yılmaz, Bulent Yilmaz
Contraception · 2012 · vol. 86(5) , pp. 458–463 · doi:10.1016/j.contraception.2012.04.001 · PMID:22832203 · W2017809041
Non-randomised trial OA: closed CC0 ⤵ 20 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-08 ⓘ

This study compared the effects of levonorgestrel-releasing intrauterine systems and T380A copper intrauterine devices on dysmenorrhea and bleeding patterns in women with and without adenomyosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

BACKGROUND: The study was conducted to compare the levonorgestrel intrauterine system (LNG-IUS) and Copper T380A intrauterine device (IUD) in women with and without adenomyosis and to investigate the effects on menstruation and dysmenorrhea. STUDY DESIGN: Women diagnosed as having adenomyosis on transvaginal ultrasound were assigned to receive LNG-IUS (Group 1, n=23), and women seeking contraception were assigned to receive either LNG-IUS (Group 2, n=25) or Copper T380A IUD (Group 3, n=26) for 12 months. RESULTS: The LNG-IUS significantly improved the duration of menstrual bleeding, dysmenorrhea and hemoglobin levels at the 1st and 12th month of the treatment in Group 1 and Group 2 as compared to Group 3. Moreover, LNG-IUS had similar efficacy but significantly lower side effects when compared to Copper T380A regarding contraception. However, acne was significantly increased after insertion in women using LNG-IUS. CONCLUSIONS: The LNG-IUS results in significant improvements in adenomyosis-associated heavy menstrual bleeding and dysmenorrhea. Moreover, this study also shows that it is an effective contraceptive method with significantly lower side effects compared to CuT 380A IUD except for acne.

My notes (saved in your browser only)

Condition tags

dysmenorrheaadenomyosis

MeSH descriptors

Adenomyosis Dysmenorrhea Intrauterine Devices, Copper Intrauterine Devices, Copper Intrauterine Devices, Copper Intrauterine Devices, Medicated Intrauterine Devices, Medicated Intrauterine Devices, Medicated Levonorgestrel Menorrhagia Adenomyosis Adenomyosis Adult Adult Contraceptive Agents, Female Contraceptive Agents, Female Dysmenorrhea Dysmenorrhea Dysmenorrhea Female

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (47)

Cited by (19)

Source provenance

europepmc
last seen: 2026-10-12T06:17:10.165071+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:10:37.302907+00:00
unpaywall
last seen: 2026-10-12T06:33:14.382917+00:00
License: CC0 · commercial use OK